$20.57
$0.00 (0.00%)
End-of-day quote: 05/24/2024
NasdaqGS:EXEL
Exelixis Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| MRK | Merck | NYSE | Outperform | $129.49 | $130.51 | 0.00% | 11 | $327.97B |
| ROG | Roche Holding | SWX | Hold | CHF230.40 | CHF307.83 | 0.00% | 9 | CHF185.99B |
| PFE | Pfizer | NYSE | Outperform | $28.88 | $32.87 | 0.00% | 6 | $163.65B |
| REGN | Regeneron Pharmaceuticals | NasdaqGS | Outperform | $985.02 | $961.26 | 0.00% | 8 | $106.27B |
| BMY | Bristol-Myers Squibb | NYSE | Hold | $41.24 | $58.15 | 0.00% | 10 | $83.60B |
| BAYN | Bayer | XTRA | Hold | 27.63€ | 45.15€ | 0.00% | 4 | 27.14€B |
| 4523 | Eisai | TSE | Outperform | ¥6.76k | ¥9.58k | 0.00% | 0 | ¥1.97T |
| INCY | Incyte | NasdaqGS | Outperform | $57.31 | $77.05 | 0.00% | 8 | $12.01B |
| JAZZ | Jazz Pharmaceuticals | NasdaqGS | Outperform | $106.06 | $188.32 | 0.00% | 4 | $7.13B |
| BPMC | Blueprint Medicines | NasdaqGS | Outperform | $102.81 | $85.71 | 0.00% | 5 | $6.78B |
| IONS | Ionis Pharmaceuticals | NasdaqGS | Outperform | $37.28 | $55.60 | 0.00% | 3 | $5.76B |
